Search

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients. Read the full article here.

Brain Canada, the Huntington Society of Canada (HSC), and the River Philip Foundation are pleased to announce the recipients of the 2025 Navigator Awards. HSC’s Navigator Research Program is designed to provide funding for Canadian scientific research projects of direct and immediate relevance to...

Eight Undergraduate Students across Canada are receiving fellowships through Brain Canada and the Huntington Society of Canada. The 2025 Undergraduate Student Fellowships is a program designed to attract the brightest young scientists into the field of Huntington disease research and to facilitate...

(Kitchener, ON) May 16, 2017 – Bev Heim-Myers, Chief Executive Officer of the Huntington Society of Canada (HSC), and Inez Jabalpurwala, President and Chief Executive Officer of the Brain Canada Foundation, are pleased to announce the 2017 recipient of the HD Clinician-Scientist-to-Patient Virtual...

For Nathalie, some of the most difficult parts of her TBI are expressing herself and loneliness. When we spoke over a video call with Nathalie B. Morin for this interview, she was lying in bed, with her nose taped after a physiotherapy treatment. Prior to 2015, she experienced seven car accidents...

Researchers demonstrating the Mydriatic Hyperspectral Retinal Camera, part of Optina’s Retinal Deep PhenotypingTM platform Dr. Jean-Paul Soucy. Dr Soucy, in collaboration with Optina Diagnostics, has developed an eye test that could revolutionize the early diagnosis of Alzheimer’s Disease...

A recent study by the Massague group has identified genes that mediated breast cancer metastasis to the brain by using genomic expression analysis to compare in vivo-selected brain metastasis cell lines to the corresponding parental lines. Project Overview A recent study by the Massague group has...

Earlier diagnosis of ALS remains one of the biggest goals of researchers worldwide and it is likely that the effectiveness of future treatment discoveries will be magnified by their application at a time point closer to symptom onset. Project Overview Earlier diagnosis of ALS remains one of the...

Amyotrophic Lateral Sclerosis (ALS) can result from many different mutations in the same gene, making mutation-specific treatments challenging. Project Overview Amyotrophic Lateral Sclerosis (ALS) can result from many different mutations in the same gene, making mutation-specific treatments...

Stroke is the leading cause of disability among adults and one of the three leading causes of death in North America. Project Overview Stroke is the leading cause of disability among adults and one of the three leading causes of death in North America. Intracranial aneurysm (IA) is one of the main...